Company profile · Biotech & medical
泰宗生物科技股份有限公司 · 4169
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
TCM Biotech International Corp. develops new drugs, medical devices, and functional foods.[1]
The company's products include intra-articular injections, platelet-rich plasma separation products, lipolytic injections, ventilators, iron supplements, and urological and surgical products.[2]
It also focuses on biotechnological new drug development and detection platforms for liver diseases.[2]
After subscribing, check your inbox (and spam folder) and confirm your subscription. We do this to protect you from spammers.
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$62m | +10.2% | -0.6% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-15 to 2026-11-13 | +NT$9m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | TCM BIOTECH INTERNATIONAL CORP. |
|---|---|
| Chinese name | 泰宗生物科技股份有限公司 |
| Stock code | 4169 (TWSE) |
| Industry | Biotech & medical |
| Founded | 20 Feb 1998 |
| Listed | 08 Apr 2026 |
| Paid-in capital | NT$664m |
| Chairman | 徐煥清 |
| President | 王雅俊 |
| Headquarters | 24F-8, No.97, Sec. 1, Xintai 5th Rd., Xizhi Dist New Taipei City , Taiwan (R.O.C.) |
| Website | http://www.tcmbio.com/ |
| Official business description | 新藥及醫療器材之研發 · 西藥產品、醫療器材、健字號產品、機能性食品製造、買賣 |
Facts from MOPS company basic information, retrieved 12 Nov 2026. The official business description is the company's own entry and can be out of date.
After subscribing, check your inbox (and spam folder) and confirm your subscription. We do this to protect you from spammers.
Generated 2026-11-15 00:39.